- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Osteoporosis
- Meeting Date: March 2020
- Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
- Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)
Romosozumab – March 2020
Romosozumab: Injection 105 mg in 1.17 ml single use pre-filled syringe; Evenity®
Last updated
3 July 2020